Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors
Mouhamed Nashawi, Omar Sheikh, Ayman Battisha, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 3, pp. 643-652
Closed Access | Times Cited: 11

Showing 11 citing articles:

Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus
Sahar Mohamed El-Haggar, Yasser Mostafa Hafez, Amira Mohamed El Sharkawy, et al.
Medicina Clínica (2024) Vol. 163, Iss. 2, pp. 53-61
Closed Access | Times Cited: 5
Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
Mohamed El‐Shafey, Mosaab Salah El-din El-Agawy, Mohamed K. El-Kherbetawy, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 21
NEW DIRECTIONS IN PHARMACOLOGICAL TREATMENT WITH SGLT-2 INHIBITOR MOLECULES IN THE LIGHT OF CURRENT GUIDELINES FOR DIABETES MELLITUS, HEART FAILURE AND KIDNEY DISEASE
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 4, pp. 686-696
Open Access | Times Cited: 7
Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study
Jingxing Li, Yu-Tung Hung, Henry Bair, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Therapeutic Screening of Herbal Remedies for the Management of Diabetes
Mahmoud Balbaa, Marwa El‐Zeftawy, Shaymaa A. Abdulmalek
Molecules (2021) Vol. 26, Iss. 22, pp. 6836-6836
Open Access | Times Cited: 17
Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus
Sahar Mohamed El-Haggar, Yasser Mostafa Hafez, Amira Mohamed El Sharkawy, et al.
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 2, pp. 53-61
Closed Access
The effect of SLGT2 inhibitors on serum electrolyte levels, kidney function and NT-proBNP in patients with heart failure with preserved and reduced ejection fraction
Marin Viđak, Petra Vitlov, Jasmina Ćatić, et al.
Cardiologia Croatica (2024) Vol. 19, Iss. 11-12, pp. 448-449
Open Access
Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy
Mouhamed Nashawi, Mahmoud Ahmed, Toka Amin, et al.
World Journal of Cardiology (2021) Vol. 13, Iss. 12, pp. 676-694
Open Access | Times Cited: 2
Sodium-glucose cotransporter-2 inhibitors: A treatment option for recurrent vasovagal syndrome?
Despina Sanoudou, Christos S. Mantzoros, Michael A. Hill
Metabolism (2022) Vol. 137, pp. 155309-155309
Closed Access | Times Cited: 1
Cardioprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors and Their Possible Association With Normalization of the Circadian Index of Heart Rhythm
Nazile Bilgin Doğan, Hamiyet Yılmaz, Barış Kiliçaslan
Texas Heart Institute Journal (2023) Vol. 50, Iss. 6
Open Access
Beyond the myocardium: Sodium‐glucose co‐transporter‐2 inhibitors in heart failure
Robert Ćhilton
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1215-1218
Closed Access
Page 1

Scroll to top